During the past decade, Lenus Research & Medical Group, LLC conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 12 clinical trials were completed, i.e. on average, 52.2% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 12 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lenus Research & Medical Group, LLC" #1 sponsor was "Arena Pharmaceuticals" with 2 trials, followed by "Biohaven Pharmaceuticals, Inc." with 2 trials sponsored, "Concert Pharmaceuticals" with 2 trials sponsored, "Dermira, Inc." with 2 trials sponsored and "Ferring Pharmaceuticals" with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lenus Research & Medical Group, LLC" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Database Integrations, Inc." with 1 trials as a collaborator, "Instat Consulting, Inc." with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "Novum Pharmaceutical Research Services" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Lenus Research & Medical Group, LLC" are "Ulcerative Colitis" (5 trials), "Atopic Dermatitis" (3 trials), "Acne Vulgaris" (2 trials), "Alopecia Areata" (2 trials) and "Cardiovascular Disease" (1 trials). Many other conditions were trialed in "Lenus Research & Medical Group, LLC" in a lesser frequency.

Most popular intervention types in "Lenus Research & Medical Group, LLC" are "Drug" (22 trials), "Other" (3 trials), "Combination Product" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Etrasimod" (3 trials), "Mesalamine" (2 trials), "Olumacostat Glasaretil Gel, 5.0%" (2 trials) and "AUR101" (1 trials). Other intervention names were less common.

The vast majority of trials in "Lenus Research & Medical Group, LLC" are 23 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Lenus Research & Medical Group, LLC". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 17 completed trials in Lenus Research & Medical Group, LLC, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Lenus Research & Medical Group, LLC, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".